Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2003
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309622A2 Lat peptides and their use in assays for identifying immunosuppressants
05/14/2003EP1309618A2 Leucine-based motif and clostridial neurotoxins
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309595A2 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo(1,2-a) imidazol-2-one
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309593A2 Substituted pyrazoles
05/14/2003EP1309592A2 Substituted pyrazoles
05/14/2003EP1309591A2 Substituted pyrazoles
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309573A1 Urethane derivatives
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309553A1 New aporphine esters and their use in therapy
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1309373A2 Method and composition for altering a t cell mediated pathology
05/14/2003EP1309355A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309351A1 Dermatological formulation
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309339A2 Stimulating neutrophil function to treat inflammatory bowel disease
05/14/2003EP1309331A2 Medicine for fighting against sexual dysfunction
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003EP1240162B1 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
05/14/2003EP1192170B1 Propargyl phenyl ether a2a receptor agonists
05/14/2003EP1189595B1 Ophthalmic compositions in form of aqueous gels
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1165595B1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
05/14/2003EP1109790B1 1, 2, 4-triazole-3-thione compounds
05/14/2003EP1102746B1 Substituted phenylamidines with antithrombotic action
05/14/2003EP1042317B1 Indole derivatives as PKC-inhiboitors
05/14/2003EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation
05/14/2003EP0934313B1 N-substituted azaheterocyclic compounds
05/14/2003EP0873330B1 Diarylalkenylamine derivatives
05/14/2003EP0797427B1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
05/14/2003EP0753065B1 Antibodies against e-selectin
05/14/2003EP0749308B1 Film coated tablet of paracetamol and domperidone
05/14/2003CN1418254A Method for remodelling cell wall polysaccharide structures in plants
05/14/2003CN1418217A Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418211A 苯并咪唑衍生物 Benzimidazole derivatives
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/14/2003CN1418207A Agents correcting gene expression regulatory error
05/14/2003CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418190A N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418105A Use of MIA in immunotherapy
05/14/2003CN1418103A Polysaccharidic esters of N-derivatives of glutamic acid
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418093A ultraviolet shielding adhesive preparation
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1416893A Medicine containing recombinant human metallothionein and its prepn
05/14/2003CN1416888A White peony and licorice extract and its prepn process
05/14/2003CN1416872A Health wine for expelling wind, clearing away cold and removing dampness
05/14/2003CN1416859A Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process
05/14/2003CN1416851A Plaster for treating cancerous pain
05/14/2003CN1416829A Blood-forming and menstruation-promoting capsule
05/14/2003CN1108290C Urea derivatives
05/14/2003CN1108166C Anti-inflammation analgesic
05/14/2003CN1108158C Analgesic composition
05/14/2003CN1108155C Preparation absorbed through skin, containing woluke kinds of medicine
05/13/2003US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof
05/13/2003US6562988 16-HETE (16-hydroxyeicosatetraenoic acid) analogues such as the methanesulfonamide ester (-CO-NH-SO2-CH3); inhibiting neutrophil adhesion and neutrophil aggregation; treating stroke, inflammatory diseases
05/13/2003US6562963 Coupling using organosilicon compound
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562849 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.
05/13/2003US6562847 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562837 Use of tetrahydroisoquinoline compounds for the treatment of septicemia
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562802 Anionic ethylene amine scavenger; and cationic, hydrophilic amine containing polymer like chitosan and derivatives, cationic polyethylenes, DEAE-4, and polyornithine
05/13/2003US6562794 Cosmetic and dermatological formulations comprising flavonoids
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562342 Preventives/remedies for inflammatory intestinal disease
05/13/2003US6562335 NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
1 ... 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 ... 1272